DEANNA WILLYERD: Open Payments
NPI 1578178943 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 30 payments from 12 companies in 2025. Trend: 2023 $671 · 2024 $714 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Lilly USA, LLC | 4 | $62 |
| Amgen Inc. | 4 | $58 |
| Novo Nordisk Inc | 3 | $51 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Dexcom, Inc. | 2 | $31 |
| ABBVIE INC. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: Kerendia, MOUNJARO, EVENITY, AIRSUPRA, INJECTAFER, VOQUEZNA, Wegovy, Dexcom G6 Transmitter.
Industry payments across AL — which companies pay providers there.
